Services on Demand
- Cited by SciELO
- Access statistics
On-line version ISSN 1678-9199
J. Venom. Anim. Toxins incl. Trop. Dis vol.16 no.1 Botucatu 2010 Epub Feb 05, 2010
Oliveira API; França HSI; Kuster RMI; Teixeira LAII; Rocha LMIII
IResearch Group of Natural Products, Health Sciences Center, Federal University of Rio de Janeiro, Rio de Janeiro, Rio de Janeiro State, Brazil
IILaboratory of Microbiological Control, School of Pharmacy, Fluminense Federal University, Niterói, Rio de Janeiro State, Brazil
IIILaboratory of Natural Product Technology, School of Pharmacy, Fluminense Federal University, Niterói, Rio de Janeiro State, Brazil
The present study aimed at investigating the chemical composition of essential oil extracted from Brazilian propolis and the susceptibility of Staphylococcus aureus, Staphylococcus epidermides, Streptococcus pyogenes and Escherichia coli to this substance. The essential oil was obtained by steam distillation of propolis and examined by gas chromatography/mass spectrometry (GC/MS). In addition, the agar diffusion method using filter paper disks was employed. Antibacterial activity was measured as equivalent diameters of inhibition zones (in millimeters) after incubation at 37º C for 24 hours. From the 26 identified constituents, β-caryophyllene (12.7%), acetophenone (12.3%) and β-farnesene (9.2%) were found to be major components. New components, namely linalool, methyl hydrocinnamate, ethyl hydrocinnamate, α-ylangene, γ-elemene and valencene, are reported for the first time to be present in propolis essential oil. This oil also exhibited antibacterial activity.
Key words: Apis mellifera, propolis essential oil, terpenoids, antibacterial activity.
Propolis is a resinous substance collected, transformed and used by bees to seal holes in their honeycombs, smooth out the internal walls and protect the hive entrance against intruders. Honeybees (Apis mellifera L.) collect the resin from tree bark and leaf buds. Resin is masticated, salivary enzymes are added and the partially digested material is mixed with beeswax and used in the hive (1, 2).
In addition, propolis is known to be a health food that presents antibacterial, antioxidative, immunomodulatory, antifungal, antiviral, antiprotozoal, anti-inflammatory and antitumor activities (3-12). Bosio et al. (13) observed in vitro activity of propolis extracts and supported the efficaciousness of this natural drug against Streptcoccus pyogenes, a microorganism responsible for several otorhinolaryngological infections.
Many essential oils from propolis have been analyzed and chemical substances such as terpenoids, alcohols, aldehydes, hydrocarbons and aliphatic ketones have been reported (14-20). The chemical composition of the analyzed essential oils showed qualitative and quantitative variations due to the influence of local soil conditions and seasonal harvest periods (15).
Though the antibacterial activity of propolis essential oil from Paraná and Piauí states has been reported, the literature on the antimicrobial activity of this oil from Rio de Janeiro State is scarce (17, 21). In this study, we report the chemical composition of propolis essential oil and its capacity to inhibit the in vitro growth of Staphylococcus aureus, Staphylococcus epidermides, Streptcoccus pyogenes and Escherichia coli.
MATERIALS E METHODS
Propolis samples were collected by Apis mellifera bees in Rio de Janeiro, during Brazilian autumn time (July) and was supplied by a beekeeper co-operative (COAPI-RJ).
Extraction of Essential Oil
The sample was submitted for six hours to steam distillation using a Clevenger apparatus to produce 0.9 mL of a rich essential oil extract from 1.373 g of sample, yielding 0.06% (v/w) (22). Oil was stored at 4º C until tested and analyzed.
Gas Chromatography/Mass Spectrometry Analysis
Essential oil constituents were analyzed by a GC/MS QP-5000® (Shimadzu, Japan) gas chromatograph equipped with an electron ionization mass spectrometer. The gas-chromatographic (GC) conditions were as follows: injector temperature, 260º C; carrier gas, helium; flow rate, 1 mL/min; and split injection with split ratio, 1:40. Oven temperature was initially 60º C and then raised to 240º C at a rate of 3º C/ minute. One microliter of the sample, dissolved in CH2Cl2 (1:100 mg/µL), was injected into a ZB-5 MS column (i.d. = 0.25 mm, length = 30 m, film thickness = 0.25 mm) that was directly coupled to the mass spectrometer. The mass spectrometry (MS) conditions were ionization voltage, 70 eV, and scan rate, 1 scan/second.
The linear retention indices for all the compounds were determined by co-injection of the sample with a solution containing a homologous series of C7-C26 n-alkanes (23). The individual constituents were identified by their identical retention indices referent to the compounds known from the literature data and also by comparing their mass spectra with those stored in the NIST mass spectral libraries (24).
Staphylococcus aureus ATCC25923, Staphylococcus epidermides 25/04, Staphylococcus epidermides 194/02 and Escherichia coli ATCC36298 obtained from the culture collections of the Laboratory of Microbiological Control, School of Pharmacy, Fluminense Federal University, were used for the antibacterial activity experiments. The Streptococcus pyogenes ATCC75194 and 93007 used in this experiment were provided by the Streptococcus Laboratory, Microbial Institute, Federal University of Rio de Janeiro, courtesy of Dr. Leslie Claude Benchetrit.
Disc Diffusion Method
Antimicrobial tests were then carried out by the disc diffusion method (25). Briefly, bacterial inocula were prepared by diluting overnight cultures in saline to obtain approximately 108 CFU/mL. This suspension was spread onto Mueller-Hinton agar solid plates for S. aureus, S. epidermides and E. coli. In the case of S. pyogenes, 5% sheep blood was added to Mueller-Hinton agar. Paper discs (6 mm in diameter), previously impregnated and saturated with the propolis essential oil were placed on the agar plates. Standards discs of vancomicin (30 µg/disc), penicillin (10 U/disc) and rifampicin (5 µg/disc) were used as positive controls for Staphylococcus strains, S. pyogenes and E. coli, respectively. The agar plates were incubated at 37º C for 24 hours. Antimicrobial activity was evaluated by measuring the zone of inhibition against the test organisms. All tests were performed in triplicate.
The mean, standard deviation and coefficient of variation (CV) of the three experiments were determined. CV values of at least 15.0 signify significant differences in inhibition zones. The CV values were calculated using the Microsoft Excel® program.
RESULTS AND DISCUSSION
Chemical Composition of the Essential Oil
Propolis hydrodistillation produced a yellow volatile oil. The 26 components identified comprised 67.5% of the total oil. The qualitative and quantitative compositions of the essential oil are presented in Table 1, where the compounds are listed in the order of their elution in the ZB-5 MS column. The most abundant components were β-caryophyllene (12.7%), acetophenone (12.3%), and linalool (6.47%), followed by γ-elemene (6.25%), γ-cadinene (5.86%) and γ-muurolene (3.61%). Our results corroborate those of Clair and Peyron (14) that also found β-caryophyllene as the major constituent of essential oil from French propolis. The oxygenated monoterpenes represent 7.96% of the oil, with linalool as the main part. Sesquiterpene hydrocarbons comprised 37.58% of the oil, while β-caryophyllene, γ-elemene and γ-cadinene were also in appreciable percentages, respectively, 12.7%, 6.25% and 5.86%. The oxygenated sesquiterpene fraction consisted of 2.89% of the total oil, with spathulenol found to be the principal compound. The chemical composition reported in other studies for propolis volatile oil showed some similarities with our analyses, except for the presence of linalool, methyl hydrocinnamate, ethyl hydrocinnamate, α-ylangene, γ-elemene and valencene, which were observed for the first time in this study as components of propolis essential oil (14-20, 26).
Propolis essential oil exhibited antibacterial activity against S. aureus, S. epidermides, S. pyogenes and E. coli (Table 2). The differences in inhibition-zone diameters of S. aureus ATCC25923 (CV = 4.2%), S. epidermides 25/04 (CV = 6.0%), S. epidermides 194/02 (CV = 6.0%), S. pyogenes 93007 (CV = 3.6%) and 75194 (CV = 5.3%) and E. coli (CV = 5.9%) were not statistically significant. The antibacterial effect of propolis essential oil on S. aureus was reported by other authors (17, 20). On the other hand, the present study is the first report of antibacterial activity of propolis essential oil against E. coli and S. pyogenes. Only ethanolic extract of propolis showed antibacterial activity against these two bacteria (13, 27, 28). However, ethanolic extract and essential oil of propolis present different chemical compositions (20). Probably, diverse extraction procedures result in dissimilar chemical compounds, and ultimately, could contribute to differences in the antibacterial activities (29, 30). It is not so clear whether the antibacterial effect may be caused by a single active component or by the synergy of many active constituents found in the essential oil. Terpenoids (48.4%) were found to be the major compounds of total oil. These substances are active against bacteria, but their action mechanism is not fully understood. It is has been hypothesized to involve membrane disruption by lipophilic compounds (31). The antibacterial activity could be attributed to terpenoids, according to Sacchetti et al. (32), who found that essential oil with high terpenoid percentages is probably more effective.
The present study is the first to report the presence of linalool, methyl hydrocinnamate, ethyl hydrocinnamate, α-ylangene and γ-elemene in propolis essential oil. In addition, the study has also demonstrated the antibacterial activity of propolis essential oil against gram-negative (E. coli) and gram-positive (S. aureus, S. epidermides, S. pyogenes 93007 and 75194) bacteria. Thus, it appears that chemical properties of propolis are not only advantageous to bees, but present pharmacological value both as a natural mixture and as a natural antibacterial agent.
The authors thank COAPI-RJ for providing the propolis samples.
1. Ghisalberti E. Propolis: a review. Bee World. 1979;60(2):59-84. [ Links ]
2. Marcucci MC. Propolis: chemical composition, biological properties and therapeutic activity. Apidologie. 1995;26(2):83-99. [ Links ]
3. Gonsales GZ, Orsi RO, Fernandes Júnior A, Rodrigues P, Funari SRC. Antibacterial activity of propolis collected in different regions of Brazil. J Venom Anim Toxins incl Trop Dis. 2006;12(2):276-84. [ Links ]
4. Orsi RO, Sforcin JM, Funari SRC, Fernandes Jr A, Rodrigues P, Bankova V. Effects of propolis from Brazil and Bulgaria on Salmonella serovars. J Venom Anim Toxins incl Trop Dis. 2007;13(4):748-57. [ Links ]
5. Kumazawa S, Hamasaka T, Nakayama T. Antioxidant activity of propolis of various geographic origins. Food Chem. 2004;84(3):329-39. [ Links ]
6. Borrelli F, Maffia P, Pinto L, Ianaro A, Russo A, Capasso F, et al. Phytochemical compounds involved in the anti-inflammatory effect of propolis extract. Fitoterapia. 2002;73(Suppl 1):S53-6. [ Links ]
7. Murad JM, Calvi SA, Soares AM, Bankova V, Sforcin JM. Effects of propolis from Brazil and Bulgaria on fungicidal activity of macrophages against Paracoccidioides brasiliensis. J Ethnopharmacol. 2002;79(3):331-4. [ Links ]
8. Kujumgiev A, Tsvetkova I, Serkedjieva Y, Bankova V, Christov R, Popov S. Antibacterial, antifungal and antiviral activity of propolis of different geographic origin. J Ethnopharmacol. 1999;64(3):235-40. [ Links ]
9. Higashi KO, de Castro SL. Propolis extracts are effective against Trypanosoma cruzi and have an impact on its interaction with host cells. J Ethnopharmacol. 1994;43(2):149-55. [ Links ]
10. Ramos AFN, Miranda JL. Propolis: a review of its anti-inflammatory and healing actions. J Venom Anim Toxins incl Trop Dis. 2007;13(4):697-710. [ Links ]
11. Chen CN, Wu CL, Lin JK. Propolin C from propolis induces apoptosis through activating caspases, Bid and cytochrome C release in human melanoma cells. Biochem Pharmacol. 2004;67(1):53-66. [ Links ]
12. El-Khawaga OA, Salem TA, Elshal MF. Protective role of Egyptian propolis against tumor in mice. Clin Chim Acta. 2003;338(1-2):11-6. [ Links ]
13. Bosio K, Avanzini C, D'Avolio A, Ozino O, Savoia D. In vitro activity of propolis against Streptococcus pyogenes. Lett Appl Microbiol. 2000;31(2):174-7. [ Links ]
14. Clair G, Peyron L. The study of propolis essential oil. Riv Ital EPPOS. 1981;63(3):168-70. [ Links ]
15. Petri G, Lemberkovics E, Foldvari M. Examination of differences between propolis (bee glue) produced from different floral environments. In: Lawrence BM, Mookherjee BD, Willis BJ, editors. Flavours and fragrances: a world perspective. Amsterdam: Elsevier Sci PubI; 1988. p. 439-446. [ Links ]
16. Bankova V, Boudourova-Krasteva G, Popov S, Sforcin JM, Funari SRC. Seasonal variations in essential oil from Brazilian propolis. J Essent Oil Res. 1998;10:693-6. [ Links ]
17. Bankova V, Christov R, Popov S, Marcucci MC, Tsvetkova I, Kujumgiev A. Antibacterial activity of essential oils from Brazilian propolis. Fitoterapia. 1999; 70(2):190-3. [ Links ]
18. Bracho JC. Volatile constituents of propolis. A reality concerning its enriched chemical composition. Bol Soc Qui Peru. 2000;66(4):198-209. [ Links ]
19. Kusumoto T, Miyamoto T, Higuchi R, Doi S, Sugimoto H, Yamada H. Isolation and structures of two new compounds from the essential oil of Brazilian propolis. Chem Pharm Bull. 2001;49(9):1207-9. [ Links ]
20. Pino JA, Marbot R, Delgado A, Zumárraga C, Sauri E. Volatile constituents of propolis from honeybees and stingless bees from Yucatán. J Essent Oil Res. 2006;18(1):53-6. [ Links ]
21. Zwolan W, Meresta T. Bacteriostatic action of the volatile oils obtained from propolis extracts in relation to Staphylococcus aureus. Herba Pol. 2000;46(1):30-4. [ Links ]
22. Oliveira AP. Estudo químico e biológico da própolis do Estado do Rio de Janeiro [thesis]. Rio de Janeiro: Núcleo de Pesquisa de Produtos Naturais da Universidade Federal do Rio de Janeiro; 2007. 34 p. [ Links ]
23. Van den Dool H, Kratz PD. A generalization of the retention index system including linear temperature programmed gas-liquid partition chromatography. J Chromatogr. 1963;11:463-71. [ Links ]
24. Adams RP. Identification of essential oils components by gas chromatography/quadrupole mass spectroscopy. 3rd ed. Illinois: Allured Publishing Corporation, Carol Stream; 2001. [ Links ]
25. Clinical and Laboratory Standards Institute. M2-A9. Performance standards for antimicrobial susceptibility tests. 9th ed. Wayne: CLSI; 2006. [ Links ]
26. Borcic I, Radonic A, Grzunov K. Comparison of the volatile constituents of propolis gathered in different regions of Croatia. Flavour Fragr J. 1996;11(5): 311-3. [ Links ]
27. Christov R, Bankova V, Tsvetkova I, Kujumgiev A, Delgado Tejera A. Antibacterial furofuran lignans from Canary Islands propolis. Fitoterapia. 1999; 70(1):89-92. [ Links ]
28. Nieva Moreno MI, Isla MI, Cudmani NG, Vattuone MA, Sampietro AR. Screening of antibacterial activity of Amaicha del Valle (Tucumán, Argentina) propolis. J Ethnopharmacol. 1999;68(1-3):97-102. [ Links ]
29. Muli EM, Maingi JM. Antibacterial activity of Apis mellifera L. propolis collected in three regions of Kenya. J Venom Anim Toxins incl Trop Dis. 2007;13(3):655-63. [ Links ]
30. Mantovani RP, Rall VLM, Batalha JEN, Fernandes AAH, Fernandes Junior A. Anti-coagulase-negative Staphylococcus activity of ethanolic extracts of propolis from two Brazilian regions and synergism with antimicrobial drugs by the E-test method. J Venom Anim Toxins incl Trop Dis. 2008;14(2):357-65. [ Links ]
31. Cowan MM. Plant products as antimicrobial agents. Clin Microbiol Rev. 1999; 12(4):564-82. [ Links ]
32. Sacchetti G, Maietti S, Muzzoli M, Scaglianti M, Manfreni S, Radice M, et al. Comparative evaluation of 11 essential oils of different origin as functional antioxidants, antiradicals and antimicrobials in foods. Food Chem. 2005;91(4):621-32. [ Links ]
Adriana Passos Oliveira
Laboratório de Tecnologia de Produtos Naturais
Faculdade de Farmácia, Universidade Federal Fluminense
Rua Mário Viana 523, Niterói, RJ
Phone/fax: +55 21 2629 9575
Received: June 5, 2009
Accepted: July 30, 2009
Abstract published online: August 24, 2009
Financial source: CNPq, CAPES and FAPERJ.
Conflicts of interest: There is no conflict.